COSCIENS Biopharma Inc
NASDAQ:CSCI

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
NASDAQ:CSCI
Watchlist
Price: 2.06 USD 0.49% Market Closed
Market Cap: $7.8m

Net Margin

-119.4%
Current
Improving
by 62.2%
vs 3-y average of -181.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-119.4%
=
Net Income
$-14.9m
/
Revenue
$9.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-119.4%
=
Net Income
$-14.9m
/
Revenue
$9.1m

Peer Comparison

Country Company Market Cap Net
Margin
CA
COSCIENS Biopharma Inc
TSX:CSCI
9.1m CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...

Market Distribution

Lower than 73% of companies in Canada
Percentile
27th
Based on 4 909 companies
27th percentile
-119.4%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

COSCIENS Biopharma Inc
Glance View

Market Cap
7.8m USD
Industry
Biotechnology

COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

CSCI Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-119.4%
=
Net Income
$-14.9m
/
Revenue
$9.1m
What is COSCIENS Biopharma Inc's current Net Margin?

The current Net Margin for COSCIENS Biopharma Inc is -119.4%, which is above its 3-year median of -181.6%.

How has Net Margin changed over time?

Over the last 3 years, COSCIENS Biopharma Inc’s Net Margin has increased from -146.9% to -119.4%. During this period, it reached a low of -299.2% on Dec 31, 2022 and a high of -36.8% on Dec 31, 2023.

Back to Top